Our top priority is the health and safety of our colleagues and we continue to monitor their circumstances and provide targeted support for urgent needs.
Consistent with our Mission, the company, through direct donation and matching gifts, and our colleagues are donating more than $1.25 million towards relief efforts for Ukraine through organizations including the International Committee for the Red Cross, International Rescue Committee, and Save the Children.
Given the ongoing conflict, we have paused sales and manufacturing operations in Russia and Belarus. We continue to prioritize critical healthcare-related deliveries and operations in these countries to limit any potential patient impact. In addition, our clinical trial service delivery in Ukraine has been temporarily halted and will resume once safe to do so.
We will continue to monitor the situation and adjust accordingly.